145 related articles for article (PubMed ID: 12406546)
21. Susceptibility to urethane carcinogenesis of transgenic mice carrying a human prototype c-Ha-ras gene (rasH2 mice) and its modification by butylhydroxytoluene.
Umemura T; Kodama Y; Hioki K; Inoue T; Nomura T; Kurokawa Y
Cancer Lett; 1999 Oct; 145(1-2):101-6. PubMed ID: 10530776
[TBL] [Abstract][Full Text] [Related]
22. N-Ethyl-N-nitrosourea induces mammary cancers in the pituitary-isografted mouse which are histologically and genotypically distinct from those induced by N-methyl-N-nitrosourea.
Swanson SM; Guzman RC; Tsukamoto T; Huang TT; Dougherty CD; Nandi S
Cancer Lett; 1996 Apr; 102(1-2):159-65. PubMed ID: 8603364
[TBL] [Abstract][Full Text] [Related]
23. Lung Tumor Induction by 26-week Dermal Application of 1,2-Dichloroethane in CB6F1-Tg rasH2 Mice.
Suguro M; Numano T; Kawabe M; Doi Y; Imai N; Mera Y; Tamano S
Toxicol Pathol; 2017 Apr; 45(3):427-434. PubMed ID: 28421967
[TBL] [Abstract][Full Text] [Related]
24. NTP Toxicology and Carcinogenesis of 1,2,3-Trichloropropane (CAS No. 96-18-4) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 384():1-348. PubMed ID: 12692652
[TBL] [Abstract][Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of Benzene (CAS No. 71-43-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1986 Apr; 289():1-277. PubMed ID: 12748714
[TBL] [Abstract][Full Text] [Related]
26. Rapid induction of skin tumors in human but not mouse c-Ha-ras proto-oncogene transgenic mice by chemical carcinogenesis.
Muto S; Katsuki M; Horie S
Cancer Sci; 2006 Sep; 97(9):842-7. PubMed ID: 16805855
[TBL] [Abstract][Full Text] [Related]
27. Twenty-six-week carcinogenicity study of sulfamethoxazole in CB6F1-Tg-rasH2 mice.
Torii M; Itoh F; Yabuuchi K; Ohno K; Kominami G; Hirano K; Tasaki T; Nara H
J Toxicol Sci; 2001 May; 26(2):61-73. PubMed ID: 11429969
[TBL] [Abstract][Full Text] [Related]
28. Site-specific mutation of the human c-Ha-ras transgene induced by dimethylbenzanthracene causes tissue-specific tumors in mice.
Doi ST; Kimura M; Katsuki M
Jpn J Cancer Res; 1994 Aug; 85(8):801-7. PubMed ID: 7928625
[TBL] [Abstract][Full Text] [Related]
29. Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene.
Ogawa K; Imaida K; Masui T; Kawabe M; Hasegawa R; Kato K; Ito N; Shirai T
Carcinogenesis; 1996 Feb; 17(2):341-5. PubMed ID: 8625461
[TBL] [Abstract][Full Text] [Related]
30. The rasH2 transgenic mouse: nature of the model and mechanistic studies on tumorigenesis.
Tamaoki N
Toxicol Pathol; 2001; 29 Suppl():81-9. PubMed ID: 11695564
[TBL] [Abstract][Full Text] [Related]
31. The Tg rasH2 mouse in cancer hazard identification.
Morton D; Alden CL; Roth AJ; Usui T
Toxicol Pathol; 2002; 30(1):139-46. PubMed ID: 11890467
[TBL] [Abstract][Full Text] [Related]
32. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
[TBL] [Abstract][Full Text] [Related]
33. Genetic susceptibility to thymic lymphomas and K-ras gene mutation in mice after exposure to X-rays and N-ethyl-N-nitrosourea.
Shimada Y; Nishimura M; Kakinuma S; Ogiu T; Fujimoto H; Kubo A; Nagai J; Kobayash K; Tano K; Yoshinaga S; Bhakat KK
Int J Radiat Biol; 2003 Jun; 79(6):423-30. PubMed ID: 12963544
[TBL] [Abstract][Full Text] [Related]
34. Corneal damage induced in adult mice by a single intraperitoneal injection of N-ethyl-N-nitrosourea.
Yoshizawa K; Sasaki T; Kuro M; Miki H; Kimura A; Uehara N; Yuri T; Tsubura A
In Vivo; 2011; 25(4):609-15. PubMed ID: 21709004
[TBL] [Abstract][Full Text] [Related]
35. Twenty-six-Week carcinogenicity study of chloroform in CB6F1 rasH2-transgenic mice.
Sehata S; Maejima T; Watanabe M; Ogata S; Makino T; Tanaka K; Manabe S; Takaoka M
Toxicol Pathol; 2002; 30(3):328-38. PubMed ID: 12051550
[TBL] [Abstract][Full Text] [Related]
36. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
37. The possible mechanism of enhanced carcinogenesis induced by genotoxic carcinogens in rasH2 mice.
Okamura M; Unami A; Moto M; Muguruma M; Ito T; Jin M; Oishi Y; Kashida Y; Mitsumori K
Cancer Lett; 2007 Jan; 245(1-2):321-30. PubMed ID: 16530936
[TBL] [Abstract][Full Text] [Related]
38. Lack of susceptibility of transgenic mice carrying the human c-Ha-ras proto-oncogene (rasH2 mice) to phenolphthalein in a 6-month carcinogenicity study.
Koujitani T; Yasuhara K; Usui T; Nomura T; Onodera H; Takagi H; Hirose M; Mitsumori K
Cancer Lett; 2000 May; 152(2):211-6. PubMed ID: 10773414
[TBL] [Abstract][Full Text] [Related]
39. Progression process and safety assessment adaptation of endometrial lesions in ENU-induced 2-stage uterine carcinogenicity in a Tg-rasH2 mouse model.
Kuroda H; Kinomoto T; Ogawa S; Kawabe M; Suguro M; Naraoka H; Takamatsu K; Oishi Y
J Toxicol Pathol; 2018 Jan; 31(1):35-41. PubMed ID: 29479138
[TBL] [Abstract][Full Text] [Related]
40. Validation of transgenic mice carrying the human prototype c-Ha-ras gene as a bioassay model for rapid carcinogenicity testing.
Yamamoto S; Urano K; Koizumi H; Wakana S; Hioki K; Mitsumori K; Kurokawa Y; Hayashi Y; Nomura T
Environ Health Perspect; 1998 Feb; 106 Suppl 1(Suppl 1):57-69. PubMed ID: 9539005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]